Menu
Recruiting NCT07283003

Evaluating Postoperative Pain After Ureterorenoscopy.

No phase Interventional Ureteral Stones

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: No Double-J catheter insertion, Double-J catheter.
Who it may be relevant to
Registry conditions: Ureteral Stones. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Switzerland
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Prospective Randomized Study on the Necessity of Postoperative Stenting After Ureteroscopy (URS) for Ureteral Stones.

Overview

Comparison of routine postoperative stenting versus no stenting after ureterorenoscopy for ureteral stones to assess the necessity and impact on complication risk.

Detailed description

After a ureteroscopy (URS) for the removal of ureteral stones, a double-J stent is routinely placed. Among other measures, this is intended to prevent pain caused by ureteral swelling, small residual fragments, blood clots, and potential drainage obstructions, which could lead to colic or fever. However, the evidence supporting the benefit of this practice is limited. At the same time, many patients report discomfort due to the stent (e.g., flank pain, dysuria, frequent urination, hematuria), which can significantly impact their quality of life.

Interventions

  • Other No Double-J catheter insertion
    Ureterorenoscopy without consecutive DJ-stent insertion.
  • Procedure Double-J catheter
    Transurethral catheter insertion

Primary outcome measures

  • Postoperative pain assessment [Time frame: up to 4 weeks postoperative]
Secondary outcome measures (7)
  • Length of stay [days] [Time frame: During the hospital stay, on average 2 days]
  • Pain Assessment [Time frame: pre-/peri-/postoperative]
  • Pain Management [Time frame: pre-/peri-/postoperative]
  • Secondary need of double-J catheter [Time frame: up to 4 weeks postoperative]
  • Procedure related readmissions [Time frame: up to 4 weeks postoperative]
  • Procedure related reoperations [Time frame: up to 4 weeks postoperative]
  • Comprehensive Complication Index [Time frame: up to 4 weeks postoperative]

Eligibility criteria

Inclusion criteria

  • Age 18 years or older
  • Patients with ureteral stones scheduled for ureteroscopy (URS) and stone removal
  • Previous pre-stenting
  • Informed Consent as documented

Exclusion criteria

  • Complex ureteral conditions (e.g., known ureteral strictures)
  • Impacted stones
  • Solitary kidney
  • Patients with significant renal stones (>3mm)
  • Previous ureteral surgeries (except endoscopic stone treatments)
  • Pregnancy or suspected pregnancy

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

Switzerland · 1 center
  • Kantonsspital Baden AG — Baden

Identifiers

NCT: NCT07283003 · 2025-00665

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗